Table 4.

Presence of complications in eclamptic women who died (cases) and survivors (controls)

Characteristics	Cases, n=41(%)	Controls, n=170 (%)	cOR	95% CI	P-value
Aspiration pneumonitis					0.0036
Yes	26 (63.4)	45 (26.5)	4.82	2.03–10.63
No	15 (36.6)	125 (73.5)	1.00	Reference
Renal failure (oliguria/anuria or abnormal renal function tests)					,0.0001
Yes	32 (78.0)	37 (21.8)	12.78	5.61–29.15
No	9 (22.0)	133 (78.2)	1.00	Reference
Orofacial injury					0.0054
Yes	28 (68.3)	74 (43.5)	2.80	0.35–5.47
No	13 (31.7)	96 (56.5)	1.00	Reference
Abruptio placentae					0.6172
Yes	3 (7.3)	9 (5.3)	1.41	0.36–5.7
No	38 (92.7)	161 (94.7)	1.00	Reference
Disseminated intravascular coagulopathy					0.0005
Yes	7 (17.1)	2 (1.2)	17.29	3.34–86.84
No	34 (82.9)	168 (98.8)	1.00	Reference
Cerebral edema					0.1304
Yes	3 (7.3)	4 (2.4)	3.28	0.70–15.35
No	38 (92.7)	166 (97.6)	1.00	Reference
Pulmonary edema					0.1505
Yes	2 (4.9)	2 (1.2)	4.31	0.59–31.54
No	39 (95.1)	168 (98.8)	1.00	Reference
Severe abnormal liver function					0.0155
Yes	9 (22.0)	14 (8.3)	3.11	1.24–7.81
No	32 (78.0)	155 (91.7)	1.00	Reference

Abbreviation: cOR, crude odds ratio.